| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/01/2006 | CN1239712C Collagen used for deep-sea fish skin tissue engineering and its preparing process |
| 02/01/2006 | CN1239711C Bitterless soybean polypeptide and its production method |
| 02/01/2006 | CN1239704C Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof |
| 02/01/2006 | CN1239701C Humanised antibodies to epidermal growth factor receptor |
| 02/01/2006 | CN1239699C Method for construction of bombyx mori virus fast gene expression system utilizing bacterium transposon |
| 02/01/2006 | CN1239694C Space mutagenesis high production and highly performance bacterial and use thereof |
| 02/01/2006 | CN1239518C Membrane protein polypeptide having pre-B cell growth-supporting ability and gene thereof |
| 02/01/2006 | CN1239517C Gene recombinant fibroblast growth factor-8a polypeptide and method for preparing same |
| 02/01/2006 | CN1239516C Tumor necrosis factor relative cell death inducing ligand extracellular region mutation polypeptide and its prepn and use |
| 02/01/2006 | CN1239085C Sea Aceta chinensis high value ecolugical utilizing process |
| 01/31/2006 | US6992176 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 01/31/2006 | US6992175 monoclonal antibody, chimeras, fragments or complemaentary determining regions that bind to polypeptides; erythropoietin producing hepatocellular (Eph), biological receptors |
| 01/31/2006 | US6992174 Reducing the immunogenicity of fusion proteins |
| 01/31/2006 | US6992171 Polypeptide and its DNA |
| 01/31/2006 | US6992170 Polypeptides and polynucleotides homologous to thymosin, ephrin a receptors, and fibromodulin |
| 01/31/2006 | US6991921 Hyaluronan synthase gene and uses thereof |
| 01/31/2006 | US6991920 Peptide for use in human therapeutics and diagnostics |
| 01/31/2006 | US6991901 Administering an antibody to the polypeptide sec1; angiogenesis inhibitors |
| 01/31/2006 | US6991793 novel live vaccines for control of F. columnare in channel catfish comprising one or more rifampicin resistant mutants of F. columnare, created by multiple passaging of the native isolate on increasing concentrations of rifampicin |
| 01/26/2006 | WO2006009297A1 Construction of chimera using es cells |
| 01/26/2006 | WO2006009114A1 Il-18 receptor antagonist and pharmaceutical composition containing the antagonist |
| 01/26/2006 | WO2006008379A1 Recombinant endofucanase |
| 01/26/2006 | WO2005090552A3 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 01/26/2006 | WO2005086595A3 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | US20060021079 Promoter sequences providing male tissue-preferred expression in plants |
| 01/26/2006 | US20060021071 Cell in which genome is modified |
| 01/26/2006 | US20060021069 Antibody production methods related to disruption of peripheral tolerance in B lymphocytes |
| 01/26/2006 | US20060020124 Protein and nucleic acid sequence encoding a krill-derived cold adapted trypsin-like activity enzyme |
| 01/26/2006 | US20060020123 Gene encoding a protein having aurone synthesis activity |
| 01/26/2006 | US20060020122 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter |
| 01/26/2006 | US20060020118 Cytokine specific immunoglobulin for prevention and treatment of diabetes, autoimmune and inflammatory disorders |
| 01/26/2006 | US20060020115 Given amino acid sequence; testing substance's ability to interact with complex; mutants used in crop protection and/or soil treatment |
| 01/26/2006 | US20060020114 Apo-2DcR |
| 01/26/2006 | US20060020112 polynucleotide encoding coiled-coil domain of the Stat protein and the first three-strands of the DNA-binding domain of the Stat protein; cell expressing said polynucleotide |
| 01/26/2006 | US20060019899 EphA2 T-cell epitopes and uses therefor |
| 01/26/2006 | US20060019897 Anti-angiogenic polypeptides |
| 01/26/2006 | US20060019886 Monomer protein with bone morphogenetic activity and medicinal agent containing the same for preventing and treating diseases of cartilage and bone |
| 01/26/2006 | US20060019879 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019878 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019871 Endothelial cell apoptosis induced by fibrinogen gamma chain C-terminal fragment |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019368 Constructs for homogenously processed preparations of beta site APP-cleaving enzyme |
| 01/26/2006 | US20060019365 IKK-alpha proteins, nucleic acids and methods |
| 01/26/2006 | US20060019364 A polynucleotide that encodes human acetyl CoA carboxylase 2 (ACC2) and rat ACC2 sequences; vectors and host cells; culturing the recombinant host cell to express the polypeptide |
| 01/26/2006 | US20060019363 Cytosolic phospholipase A2-beta enzymes |
| 01/26/2006 | US20060019357 Nucleotide sequences which code for the rpsL gene |
| 01/26/2006 | US20060019351 Enhanced secretion of a polypeptide by a microorganism |
| 01/26/2006 | US20060019350 Recombinant negative strand RNA virus expression system and vacccines |
| 01/26/2006 | US20060019349 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 01/26/2006 | US20060019348 Method of mass producing silk protein and gene recombinant silk-like protein with added functionality |
| 01/26/2006 | US20060019347 Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 01/26/2006 | US20060019346 Identification of a novel bitter taste receptor T2R76 that specifically responds to brucine and prop bitter ligands |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019344 C-erbB-2 external domain: gp75 |
| 01/26/2006 | US20060019343 Pichia methanolica secretory signal |
| 01/26/2006 | US20060019342 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 01/26/2006 | US20060019341 Aminopeptidase |
| 01/26/2006 | US20060019340 for diagnosing a rheumatoid disease; rheumatoid arthritis and psoriatic arthritis |
| 01/26/2006 | US20060019339 Measurement of bioactive hepcidins |
| 01/26/2006 | US20060019338 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods |
| 01/26/2006 | US20060019337 Dual expression vector system and screening methods |
| 01/26/2006 | US20060019336 Factor VII or VIIa - like molecules |
| 01/26/2006 | US20060019335 Compositions and methods to promote c-IAP autodegradation |
| 01/26/2006 | US20060019328 Glucose dehydrogenase |
| 01/26/2006 | US20060019322 Nucleotide sequence coding polypeptide for use in diagnosis and therapy of prostate cancer |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019308 CD38 modulated chemotaxis |
| 01/26/2006 | US20060019307 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/26/2006 | US20060019305 Diagnosis and treatment of PTP related disorders |
| 01/26/2006 | US20060019297 Expression vector comprising yarrowia regulatory sequences for use in expression of preferential heterologous nucleotide sequences |
| 01/26/2006 | US20060019296 Methods of indentifying modulators of the FGF receptor |
| 01/26/2006 | US20060019294 Tyrosine kinase substrate (Tks) proteins |
| 01/26/2006 | US20060019293 Mutations of the 5' region of the human 5-HT1A gene, associated proteins of the 5' region and a diagnostic test for major depression and related mental illnesses |
| 01/26/2006 | US20060019287 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/26/2006 | US20060019283 Common marmoset-derived HPRT gene and use thereof |
| 01/26/2006 | US20060019275 Nucleic acids encoding proteins involved in sensory transduction |
| 01/26/2006 | US20060019271 Submergence-induced protein-like factors |
| 01/26/2006 | US20060019262 Activation induced deaminase (AID) |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019257 Compositions and methods for increasing protein production |
| 01/26/2006 | US20060019252 Genes and polypeptides relating to hepatocellular or colorectal carcinoma |
| 01/26/2006 | US20060019250 Method for the detection of carcinoembryonic agent and cancer diagnosis method based thereon |
| 01/26/2006 | US20060019248 mutant SH3-binding protein (SH3BP2) nucleic acids, polypeptides, and agents which selectively bind to the mutant SH3BP2 molecules and which do not bind to the wild type SH3BP2 molecules |
| 01/26/2006 | US20060019238 Method for identifying protein-protein interactions |
| 01/26/2006 | US20060018932 Recombinant protein containing a C-terminal fragment of Plasmodium MSP-1 |
| 01/26/2006 | US20060018924 Recombinantly produced, enzymatically active, includes two amino acid motifs |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018916 Compositions and methods for eliciting an immune response to gram-negative bacterial infections |
| 01/26/2006 | US20060018915 Heteroclitic analogs and related methods |
| 01/26/2006 | US20060018906 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis |
| 01/26/2006 | US20060018905 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 01/26/2006 | US20060018903 Tumor necrosis factors (TNF); site-directed mutagenesis, genetic deletions; monoclonal antibodies with decreased immunogenicity and lymphocyte epitopes; major histocompatibility complex binding ligands; for treatment of rheumatoid arthritis and Crohn's disease |
| 01/26/2006 | US20060018898 Antibody variants |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018892 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis |
| 01/26/2006 | US20060018859 Modified human serum albumin with reduced or eliminated affinity to chemical or biological contaminants at Cys 34 |
| 01/26/2006 | US20060016107 Photo ID cards and methods of production |
| 01/26/2006 | CA2612303A1 Anti-glycated cd59 antibodies and uses thereof |